FSCN1 and systemic sclerosis: No relevant studies have explored the relationships between FSCN1 and SSc; however, its expression is associated with epithelial–mesenchymal transitions (EMTs) in other fibrotic diseases, where the EMT process can be reversed by inhibiting such expression (Fu et al., 2020).